Evaluation of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio and Red Blood Cell Distribution Width–Platelet Ratio for Diagnosis of Premature Ovarian Insufficiency
Objective: To evaluate whether systemic inflammatory markers (neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and red blood cell distribution width (RDW) to platelet ratio (RPR)) can be used as reliable markers for the diagnosis of premature ovarian insufficiency (POI) and to determine if there is a relationship between these markers and follicle stimulating hormone (FSH), Anti-Müllerian Hormone (AMH) levels.
Materials and methods: Written and electronic medical records were reviewed using searches for diagnoses with the terms of 'premature ovarian failure', 'premature ovarian insufficiency'. Patients younger than the age of 40 were diagnosed to have premature ovarian insufficiency based on their menstrual history and sonographic examination and they were compared with healthy females. Complete blood counts, day-3 hormone profiles, AMH levels of all subjects were analyzed.
Results: NLR was statistically higher in POI group compared with controls (p < 0.05). NLR had a positive correlation between FSH (r = 0.23, p = 0.045) and a negative association with AMH (r = - 0.27, p = 0.018). The area under ROC curve for NLR in POI was 0.66, with a threshold value 1.5 and sensitivity = 75.7 % and specificity = 46.0 %.
Conclusion: NLR can be a marker for the diagnosis of POI. There is a close relationship between NLR and ovarian reserve markers such as FSH and AMH.
Jewelwicz R, Schwartz M. Premature ovarian failure. Bull N Y Acad Med 1986;62:219-36.
Laughlin D, ThorneyCroft IH. Amenorrhea. In: Decherne AH, Nathan LI, eds. Current Obstetric & Gynecologic Diagnosis & Treatment. 9th ed. New York: McGraw-Hill; 2003: 991-1000.
Board JA, Redwine FO, Moncure CW, Frable WJ,
Taylor JR. Identification of differing etiologies of clinically diagnosed premature menopause. Am J Obstet Gynecol 1979; 134:936-44.
Pal L, Santoro N. Premature ovarian failure(POF): discordance between somatic and reproductive aging. Ageing Res Rev 2002;1:413-23.
Rees M, Purdie D. Premature menopause. In: Rees M, Purdie D, editors, Management of the menopause: the handbook. London: Royal Society of Medicine Press Ltd;2006; 142-49.
Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360:606-14.
Khole V. Does ovarian autoimmunity play a role in the pathophysiology of premature ovarian insufficiency? J Midlife Health 2010;1:9-13.
Ebrahimi M, Akbari Asbagh F. Pathogenesis and causes of prematüre ovarian failure: An update. Int J Fertil Steril 2011;5:54-65.
Matzuk MM, Lamb DJ. The biology of infertility: research advances and clinical challenges. Nat Med 2008;14:1197–213.
Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007;28:521–74.
Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007;73:215–20.
Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, Lee K. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 2009;58:15–23.
Azab B, Jaglall N, Atallah JP, Lamet A, Raja-Surya V, Farah B, et al. Neutrophil-lymphocyte ratio as a predictor of advers outcomes of acute pancreatitis. Pancreatology 2011;11:445–52.
Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 2013;88:218–30.
Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, Ress AL, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 2013;109:416–21.
Zheng YB, Zhao W, Liu B,Lu LG, He X, Huang JW, et al. The blood neutrophil to lymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev
Tanoglu A, Karagoz E. Predictive role of neutrophil to lymphocyte ratio in patients with advanced hepatocelluler carcinoma receiving sorafenib. Asian Pac J Cancer Prev 2014;15:1063.
İlhan M, İlhan G, Gök AF, Bademler S, Verit Atmaca F, Ertekin C. Evaluation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and red blood cell distribution width-platelet ratio as early predictor of acute pancreatitis in pregnancy. J Matern Fetal Neonatal Med 2016;29:1476-80.
Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Greggio NA, et al. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison’s disease. J Clin Endocrinol Metab 1997;82: 932–8.
van Der Voort DJ, van Der Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int 2003;14: 525–30.
Schmidt PJ, Cardoso GM, Ross JL, Haq N, Rubinow DR, Bondy CA. Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA 2006;295: 1374– 6.
Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65: 161–6.
Chen B, Ye B, Zhang J, Ying L, Chen Y. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PLoS ONE 2013;8:e68780.
Cetinkaya E, Senol K, Saylam B, Tez M. Red cell distribution width to platelet ratio: new and promising prognostic marker in acute pancreatitis. World J Gastroenterol 2014;20:14450–4.
Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 2004;10:163-75.
Yan G, Schoenfeld D, Penney C, Hurxthal K, Taylor AE, Faustman D. Identification of premature ovarian failure patients underlying autoimmunity. J Womens Health Gend Based Med 2000;9:275-87.
Mutlu MF, Erdem A. Evaluation of ovarian reserve in infertile patients. J Turk Ger Gynecol Assoc 2012;13:196–203.
Göksedef BP, Idiş N, Görgen H, Rüstemoğlu Asma Y, Api M, Çetin A. The correlation of the antral follicle count and serum anti-mullerian hormone. J Turk Ger Gynecol Assoc 2010;11:212–5.
Ledger WL. Clinical utility of measurement of anti-
mullerian hormone in reproductive endocrinology.
J Clin Endocrinol Metab 2010;95:5144–54.
Michels AW, Gottlieb PA. Autimmune polyglandular syndromes. Nat Rev Endocrinol 2010;6:270–7.
Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 2011;9:116.
Gleicher N, Weghofer A, Kim A, Barad DH. The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve. PLoS ONE 2012;7:e33638.
Nelson SM, Anderson RA, Broekmans FJ, Raine-Fenning N, Fleming R, La Marca A. Anti-Müllerian hormone: clairvoyance or crystal clear? Hum Reprod 2012;27:631–6.
Kushnir VA, Himaya E, Barad DH, Weghofer A, Gleicher N. Functional ovarian reserve assessment in young oocyte donors based on FMR1 genotypes and sub-genotypes. Fertil Steril 2013;100:S114.
Sen A, Kushnir VA, Barad DH, Gleicher N. Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol 2014;10:37–50.
Alipour F, Rasekhjahromi A, Maalhagh M, Sobhanian S, Hosseinpoor M. Comparison of Specificity and Sensitivity of AMH and FSH in Diagnosis of Premature Ovarian Failure. Dis Markers 2015;2015:585604.
|Issue||Vol 10, No 4 (December 2016)|
|Inflammation Marker Premature Ovarian Insufficiency|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|